Pub. Date : 2016 May 15
PMID : 27179115
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Correction: A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer. | Ralimetinib | mitogen-activated protein kinase 14 | Homo sapiens |